Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Acute Myeloid Leukemia Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Acute Myeloid Leukemia Drugsmarket, defines the market attractiveness level of Acute Myeloid Leukemia Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Acute Myeloid Leukemia Drugs industry, describes the types of Acute Myeloid Leukemia Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Acute Myeloid Leukemia Drugs market and the development prospects and opportunities of Acute Myeloid Leukemia Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Acute Myeloid Leukemia Drugs market in Chapter 13.
By Player:
Sunesis Pharmaceuticals
Ambit Biosciences Corporation
Celgene Corporation
Eisai
Genzyme Corporation
Clavis Pharma
Cephalon
By Type:
DC regimen
AVD Regimen
VCD regimen
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Acute Myeloid Leukemia Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Acute Myeloid Leukemia Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Acute Myeloid Leukemia Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Acute Myeloid Leukemia Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Acute Myeloid Leukemia Drugs Market Analysis and Outlook to 2022
-
7.1 Global Acute Myeloid Leukemia Drugs Consumption (2017-2022)
-
7.2 United States Acute Myeloid Leukemia Drugs Consumption (2017-2022)
-
7.3 Europe Acute Myeloid Leukemia Drugs Consumption (2017-2022)
-
7.4 China Acute Myeloid Leukemia Drugs Consumption (2017-2022)
-
7.5 Japan Acute Myeloid Leukemia Drugs Consumption (2017-2022)
-
7.6 India Acute Myeloid Leukemia Drugs Consumption (2017-2022)
-
7.7 South Korea Acute Myeloid Leukemia Drugs Consumption (2017-2022)
8 Region and Country-wise Acute Myeloid Leukemia Drugs Market Analysis and Outlook to 2028
-
8.1 Global Acute Myeloid Leukemia Drugs Consumption Forecast (2022-2028)
-
8.2 United States Acute Myeloid Leukemia Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Acute Myeloid Leukemia Drugs Consumption Forecast (2022-2028)
-
8.4 China Acute Myeloid Leukemia Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Acute Myeloid Leukemia Drugs Consumption Forecast (2022-2028)
-
8.6 India Acute Myeloid Leukemia Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Acute Myeloid Leukemia Drugs Consumption Forecast (2022-2028)
9 Global Acute Myeloid Leukemia Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Acute Myeloid Leukemia Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global DC regimen Consumption and Growth Rate (2017-2022)
-
9.1.2 Global AVD Regimen Consumption and Growth Rate (2017-2022)
-
9.1.3 Global VCD regimen Consumption and Growth Rate (2017-2022)
-
9.2 Global Acute Myeloid Leukemia Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Acute Myeloid Leukemia Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Acute Myeloid Leukemia Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global DC regimen Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global AVD Regimen Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global VCD regimen Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Acute Myeloid Leukemia Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Acute Myeloid Leukemia Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Acute Myeloid Leukemia Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Acute Myeloid Leukemia Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Acute Myeloid Leukemia Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Acute Myeloid Leukemia Drugs Market Competitive Analysis
-
14.1 Sunesis Pharmaceuticals
-
14.1.1 Sunesis Pharmaceuticals Company Details
-
14.1.2 Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Product and Service
-
14.2 Ambit Biosciences Corporation
-
14.2.1 Ambit Biosciences Corporation Company Details
-
14.2.2 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Product and Service
-
14.3 Celgene Corporation
-
14.3.1 Celgene Corporation Company Details
-
14.3.2 Celgene Corporation Acute Myeloid Leukemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Celgene Corporation Acute Myeloid Leukemia Drugs Product and Service
-
14.4 Eisai
-
14.4.1 Eisai Company Details
-
14.4.2 Eisai Acute Myeloid Leukemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eisai Acute Myeloid Leukemia Drugs Product and Service
-
14.5 Genzyme Corporation
-
14.5.1 Genzyme Corporation Company Details
-
14.5.2 Genzyme Corporation Acute Myeloid Leukemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Genzyme Corporation Acute Myeloid Leukemia Drugs Product and Service
-
14.6 Clavis Pharma
-
14.6.1 Clavis Pharma Company Details
-
14.6.2 Clavis Pharma Acute Myeloid Leukemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Clavis Pharma Acute Myeloid Leukemia Drugs Product and Service
-
14.7 Cephalon
-
14.7.1 Cephalon Company Details
-
14.7.2 Cephalon Acute Myeloid Leukemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Cephalon Acute Myeloid Leukemia Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Acute Myeloid Leukemia Drugs
-
Figure Acute Myeloid Leukemia Drugs Picture
-
Table Global Acute Myeloid Leukemia Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acute Myeloid Leukemia Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acute Myeloid Leukemia Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Acute Myeloid Leukemia Drugs Consumption by Country (2017-2022)
-
Figure United States Acute Myeloid Leukemia Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Acute Myeloid Leukemia Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Acute Myeloid Leukemia Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Acute Myeloid Leukemia Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Acute Myeloid Leukemia Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Acute Myeloid Leukemia Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Myeloid Leukemia Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Acute Myeloid Leukemia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Acute Myeloid Leukemia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Acute Myeloid Leukemia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Acute Myeloid Leukemia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Acute Myeloid Leukemia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Acute Myeloid Leukemia Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global DC regimen Consumption and Growth Rate (2017-2022)
-
Figure Global AVD Regimen Consumption and Growth Rate (2017-2022)
-
Figure Global VCD regimen Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global DC regimen Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AVD Regimen Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global VCD regimen Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Acute Myeloid Leukemia Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Acute Myeloid Leukemia Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Sunesis Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sunesis Pharmaceuticals Acute Myeloid Leukemia Drugs Product and Service
-
Table Ambit Biosciences Corporation (Foundation Year, Company Profile and etc.)
-
Table Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ambit Biosciences Corporation Acute Myeloid Leukemia Drugs Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Acute Myeloid Leukemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Acute Myeloid Leukemia Drugs Product and Service
-
Table Eisai (Foundation Year, Company Profile and etc.)
-
Table Eisai Acute Myeloid Leukemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Acute Myeloid Leukemia Drugs Product and Service
-
Table Genzyme Corporation (Foundation Year, Company Profile and etc.)
-
Table Genzyme Corporation Acute Myeloid Leukemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme Corporation Acute Myeloid Leukemia Drugs Product and Service
-
Table Clavis Pharma (Foundation Year, Company Profile and etc.)
-
Table Clavis Pharma Acute Myeloid Leukemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clavis Pharma Acute Myeloid Leukemia Drugs Product and Service
-
Table Cephalon (Foundation Year, Company Profile and etc.)
-
Table Cephalon Acute Myeloid Leukemia Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cephalon Acute Myeloid Leukemia Drugs Product and Service
-
